Orchestra BioMed Holdings (OBIO) Asset Utilization Ratio (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Asset Utilization Ratio for 5 consecutive years, with 0.3 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 611.45% year-over-year to 0.3; the TTM figure through Mar 2026 stood at 0.3 (up 611.45% YoY), while the FY2025 annual figure was 0.35, up 1038.7% from the prior year.
• Asset Utilization Ratio steadied at 0.3 in Q1 2026 per OBIO's latest filing, from 0.3 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.3 in Q4 2025 and bottomed at 0.02 in Q1 2024.
• Historically, Asset Utilization Ratio has averaged 0.07 across 5 years, with a median of 0.04 in 2024.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio plunged 39.36% — and 2025, when it surged 775.32%.
• Orchestra BioMed Holdings' Asset Utilization Ratio stood at 0.04 in 2022, then sank by 39.36% to 0.03 in 2023, then surged by 33.48% to 0.03 in 2024, then surged by 775.32% to 0.3 in 2025, then dropped by 0.38% to 0.3 in 2026.
• Business Quant data shows OBIO's Asset Utilization Ratio at 0.3 in Q1 2026, 0.3 in Q4 2025, and 0.04 in Q3 2025.